Murli Krishna Pharma Private Ltd is a young and dynamic drug delivery systems (DDS) company in India that provides a range of effective solutions to optimize the delivery of pharmaceutical products.
Murli Krishna Pharma Private Ltd. was established by MS. Satya Vadlamani & Dr. Vijay K. Shastri in early 2004.
Driven by the vision to provide the best possible, range of international quality products at competitive prices through integration, research, innovation, technology & development.
MKPPL plant is approved for manufacturing by European Union & for GMP Compliance by the WHO:
Murli Krishna Pharma is equipped to undertake formulation development projects on oral NDDS. And the R&D facility is recently approved by DSIRT.
MKPPL have a world class oral solid dosage form manufacturing facility for Pellets, Micro-Pellets and Granules approved by regulatory authorities of developed countries.
Company want to carve out a niche in the field of Novel Drug Delivery System(NDDS) & would like to be known as one of the Leading Global Research Based, Drug Delivery Companies, with an expertise in novel drug delivery systems, constantly strive towards building and strengthening upon our intellectual property.
Current activities include manufacturing of pre—finished formulations i.e. pellets using Aqueous Based technology and avoiding use of Solvents completely. We have 3 potential IPRs. We develop platform technology implement the same.